NO953579D0 - Konsentrert vevskultur-produsert levende T. Gondii Bradyzoite og produkter derav - Google Patents

Konsentrert vevskultur-produsert levende T. Gondii Bradyzoite og produkter derav

Info

Publication number
NO953579D0
NO953579D0 NO953579A NO953579A NO953579D0 NO 953579 D0 NO953579 D0 NO 953579D0 NO 953579 A NO953579 A NO 953579A NO 953579 A NO953579 A NO 953579A NO 953579 D0 NO953579 D0 NO 953579D0
Authority
NO
Norway
Prior art keywords
products
tissue culture
produced live
concentrated tissue
gondii bradyzoite
Prior art date
Application number
NO953579A
Other languages
English (en)
Norwegian (no)
Inventor
Karen K Brown
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO953579D0 publication Critical patent/NO953579D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • C12N1/105—Protozoal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/90—Protozoa ; Processes using protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO953579A 1994-09-12 1995-09-11 Konsentrert vevskultur-produsert levende T. Gondii Bradyzoite og produkter derav NO953579D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30430894A 1994-09-12 1994-09-12

Publications (1)

Publication Number Publication Date
NO953579D0 true NO953579D0 (no) 1995-09-11

Family

ID=23175953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953579A NO953579D0 (no) 1994-09-12 1995-09-11 Konsentrert vevskultur-produsert levende T. Gondii Bradyzoite og produkter derav

Country Status (6)

Country Link
EP (1) EP0700991A1 (ja)
JP (1) JPH08187076A (ja)
AU (1) AU3046595A (ja)
BR (1) BR9503991A (ja)
NO (1) NO953579D0 (ja)
NZ (1) NZ272921A (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1934899A (en) 1997-12-19 1999-07-12 Heska Corporation Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
WO2019241579A1 (en) * 2018-06-13 2019-12-19 Wisconsin Alumni Research Foundation Toxoplasma gondii vaccine
JP2022522112A (ja) 2019-02-08 2022-04-14 ウィスコンシン アルムニ リサーチ ファンデイション ヒト化細胞系
JP2022551805A (ja) 2019-08-27 2022-12-14 ウィスコンシン アルムニ リサーチ ファンデイション 卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045313A (en) * 1989-07-07 1991-09-03 The University Of Kansas Vaccine for immunizing cats against toxoplasma oocyst shedding

Also Published As

Publication number Publication date
AU3046595A (en) 1996-03-28
NZ272921A (en) 1996-03-26
EP0700991A1 (en) 1996-03-13
JPH08187076A (ja) 1996-07-23
BR9503991A (pt) 1996-09-24

Similar Documents

Publication Publication Date Title
DK0865778T3 (da) Hygiejniske og medicinske produkter
NO983235D0 (no) Fikstur og protese innbefattende samme
IS4481A (is) Díhýdrópyramídín og notkun þeirra
DK0815861T3 (da) Sulfonamider og anvendelse deraf
DE69215639D1 (de) Endoskop
IT1277860B1 (it) Dispositivo simmetrizzatore e procedimento per la sua progettazione.
NO981079D0 (no) Bakterieavvisende og blodforlikelig modifiserte overflater
NO20010326L (no) FSH og FSH-variantformuleringer, produkter og fremgangsmÕter
IS4921A (is) Lækningatæki
NO951447D0 (no) Organoaluminoksyprodukt, fremstilling og anvendelse
DE69512853D1 (de) Bilderzeugungsverfahren und -Vorrichtungen
FI920152A (fi) Kirurgisk borrschablon.
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
NO953579D0 (no) Konsentrert vevskultur-produsert levende T. Gondii Bradyzoite og produkter derav
DE69112921D1 (de) Hygiene- und Behandlungsvorrichtung.
NO982942D0 (no) Blodforenlig og bakterieavvisende blokkopolymer
FR2752317B1 (fr) Terminal medical et paramedical
NO982930D0 (no) Blodforenlig og bakterieavvisende kopolymer
NO900271D0 (no) Forbindelse og anvendelse.
NO905221D0 (no) Steriliseringsblandinger og anvendelse derav.
NO985572L (no) Substituerte amidinobenzenderivater og medisinske preparater derav
NO901052D0 (no) 1h-pyrazol-1-acetamider og fremstilling derav.
NO901828D0 (no) Poroese polymerkuler og fremgangsmaate.
KR940026468U (ko) 인재
DK291289A (da) Anvendelse af 11-substituerede 5,11-dihydro-6h-pyridooe2,3-baa-oe1,4aabenzodiazepinoner til behandling af bradycardier og bradyarrhytmier hos mennesker og dyr